[HTML][HTML] Amisulpride withdrawal dyskinesia: a case report

YC Lo, YC Peng - Annals of General Psychiatry, 2017 - Springer
YC Lo, YC Peng
Annals of General Psychiatry, 2017Springer
Background The effects of antipsychotic drug withdrawal have been inadequately studied.
Case reports have described dyskinesia occurring in patients with several antipsychotics
withdrawn, but studies on amisulpride withdrawal dyskinesia are lacking. Case presentation
A 63-year-old man, who was diagnosed with schizophrenia at age 49, received amisulpride
treatment since age 62. The dosage of amisulpride was reduced from 200 to 50 mg/day
because of occurrence of akathisia during one admission. Severe withdrawal dyskinesia …
Background
The effects of antipsychotic drug withdrawal have been inadequately studied. Case reports have described dyskinesia occurring in patients with several antipsychotics withdrawn, but studies on amisulpride withdrawal dyskinesia are lacking.
Case presentation
A 63-year-old man, who was diagnosed with schizophrenia at age 49, received amisulpride treatment since age 62. The dosage of amisulpride was reduced from 200 to 50 mg/day because of occurrence of akathisia during one admission. Severe withdrawal dyskinesia, mixed with dystonia and akathisia, was noted immediately after the dosage reduction. The abnormal involuntary movement showed improvement 2 weeks later when the dosage was increased to 100 mg/day.
Conclusions
Withdrawal dyskinesia and other abnormal involuntary movements could be noted in a patient with reduction of amisulpride dosage or sudden termination. Withdrawal dyskinesia may subsequently lead to persistent tardive dyskinesia. Therefore, withdrawal-emergent dyskinesia should be promptly identified, and appropriate medical interventions should be given early.
Springer
以上显示的是最相近的搜索结果。 查看全部搜索结果